Сhanges of cortisol level in patients with COVID-19 and cognitive disorders

dc.contributor.author	Sarakhan, V. M.	en
dc.date.accessioned	2025-03-07T07:00:54Z
dc.date.available	2025-03-07T07:00:54Z
dc.date.issued	2023
dc.identifier.citation	Sarakhan V. M. Сhanges of cortisol level in patients with COVID-19 and cognitive disorders // Journal of Education, Health and Sport. 2023. Vol. 13, n. 5. P. 213–218.	en
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/17068
dc.description.abstract	The article is presents results of the changes pf cortisol level in patients with COVID- 19 and cognitive disorders. It was established increase the main marker of stress – cortisol relative to the physiological norm in all age groups of patients who suffered from COVID-19 and were hospitalized. In the age group 40-50 years, the cortisol level increased on the first day in men on 1.4 times (p˂0.05) and in women on 1.2 times (p˂0.05) compared to the physiological norm. Therefore, cortisol can be considered a diagnostically significant trigger for the development of cognitive disorders, which will subsequently lead to drastic changes in the central nervous system.	en
dc.language.iso	en	en
dc.subject	pathogenesis	en
dc.subject	cognitive dysfunction	en
dc.subject	COVID-19	en
dc.subject	cortisol	en
dc.subject	marker	en
dc.title	Сhanges of cortisol level in patients with COVID-19 and cognitive disorders	en
dc.type	Article	en